These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5803846)

  • 21. Toxoplasma infection in patients with systemic lupus erythematosus.
    Baykal Y; Saglam K; Caliskaner Z
    J Rheumatol; 1998 Oct; 25(10):2038-9. PubMed ID: 9779870
    [No Abstract]   [Full Text] [Related]  

  • 22. High dose cyclophosphamide in the treatment of systemic lupus erythematosus.
    Mittal G; Balakrishnan C; Mangat G; Joshi VR
    J Assoc Physicians India; 1999 Jul; 47(7):747. PubMed ID: 10778607
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cytostatics in the treatment of lupous disease].
    Stroescu O; Ciobanu V; Răileanu I; Suţeanu S; Mihăilescu E; Berceanu S
    Med Interna (Bucur); 1967 Jul; 19(7):845-58. PubMed ID: 6052171
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunosuppressive drug therapy of systemic lupus erythematosus.
    Fox DA; McCune WJ
    Rheum Dis Clin North Am; 1994 Feb; 20(1):265-99. PubMed ID: 8153402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure of the war to the knife against antiphospholipid antibodies by conventional immunosuppressive therapy in systemic lupus erythematosus.
    Stratta P; Canavese C; Ferrero S; Grill A; Schinco PC; Montaruli B
    Clin Nephrol; 1996 Nov; 46(5):356. PubMed ID: 8953129
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of membranous lupus nephritis: where are we now?
    Beck LH; Salant DJ
    J Am Soc Nephrol; 2009 Apr; 20(4):690-1. PubMed ID: 19279123
    [No Abstract]   [Full Text] [Related]  

  • 27. [Drug therapy on patients with systemic lupus erythematosus].
    Kumagai S; Nakamura T
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Feb; 25(1):14-20. PubMed ID: 11963174
    [No Abstract]   [Full Text] [Related]  

  • 28. Systemic lupus erythematosus--immunoregulatory therapies.
    Miller ML; Steinberg AD
    Clin Rheum Dis; 1983 Dec; 9(3):617-28. PubMed ID: 6360516
    [No Abstract]   [Full Text] [Related]  

  • 29. [The immunosuppressive agents. 3. The immunosuppressive agents in hematology].
    Meshaka G; Jacquillat C; Sultan Y
    Presse Med (1893); 1967 Jul; 75(32):1653-5. PubMed ID: 6067478
    [No Abstract]   [Full Text] [Related]  

  • 30. Pregnancy in systemic lupus erythematosus.
    Neth J Med; 1984; 27(3):84-9. PubMed ID: 6369160
    [No Abstract]   [Full Text] [Related]  

  • 31. [Systemic lupus erythematosus: the prognosis has improved].
    Rautenstrauch J
    Dtsch Med Wochenschr; 2000 Aug; 125(33):A7-8. PubMed ID: 11023349
    [No Abstract]   [Full Text] [Related]  

  • 32. [Transformation of lymphocytes during immunosuppressive therapy in lupus erythematosus visceralis].
    Heine KM; Klatt R; Stobbe H; Apostoloff E; Jendrusch C
    Z Gesamte Inn Med; 1969 May; 24(10):152-4. PubMed ID: 5812420
    [No Abstract]   [Full Text] [Related]  

  • 33. Pimecrolimus 1% cream for cutaneous lupus erythematosus.
    Kreuter A; Gambichler T; Breuckmann F; Pawlak FM; Stücker M; Bader A; Altmeyer P; Freitag M
    J Am Acad Dermatol; 2004 Sep; 51(3):407-10. PubMed ID: 15337984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity to change of the MOS SF-36 quality of life assessment questionnaire in patients with systemic lupus erythematosus taking immunosuppressive therapy.
    Rood MJ; Borggreve SE; Huizinga TW
    J Rheumatol; 2000 Aug; 27(8):2057-9. PubMed ID: 10955362
    [No Abstract]   [Full Text] [Related]  

  • 35. [Lupus nephropathy treated with cyclosporine A. Report of 3 cases].
    García Gasalla M; Yebra Bango M; Vargas Núñez JA; López García E; Villarreal García-Lomas M; Durántez Martínez A
    Rev Clin Esp; 1997 Nov; 197(11):760-3. PubMed ID: 9580062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Looking backward: a review of the treatment of systemic lupus erythematosus in end-stage renal disease after a quarter of century.
    Diskin CJ
    Nephrol Dial Transplant; 2006 Jun; 21(6):1739. PubMed ID: 16384832
    [No Abstract]   [Full Text] [Related]  

  • 37. Lupus Nephritis.
    Adu D; Cameron JS
    Clin Rheum Dis; 1982 Apr; 8(1):153-82. PubMed ID: 6214362
    [No Abstract]   [Full Text] [Related]  

  • 38. Active necrotizing cerebral vasculitis in systemic lupus erythematosus.
    Goel D; Reddy SR; Sundaram C; Prayaga AK; Rajasekhar L; Narsimulu G
    Neuropathology; 2007 Dec; 27(6):561-5. PubMed ID: 18021377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Newer therapeutic approaches for systemic lupus erythematosus: immunosuppressive agents.
    Dooley MA; Ginzler EM
    Rheum Dis Clin North Am; 2006 Feb; 32(1):91-102, ix. PubMed ID: 16504823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of systemic lupus erythematosus systemic].
    Piette JC
    Rev Prat; 1998 Mar; 48(6):643-7. PubMed ID: 9781136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.